Domestic brokerage Motilal expects Nifty earnings to grow 25% YoY in Q1. Oil and gas sector may report a 3x surge in profit YoY underpinned...

Dr Reddy's Laboratories reported an 890% YoY surge in March quarter profit at Rs 960.1 crore but shares tumbled nearly 7% to Rs 4,545 in Th...

Tata Motors global wholesales in the fourth quarter, including Jaguar Land Rover, were at 3,61,361 units, higher by 8%, as compared to the ...

Under the terms of the agreement, Dr. Reddy’s will acquire the portfolio for an upfront payment of $90 million in cash, contingent payments...

With the acquisition of Teva’s products, sold through erstwhile Actavis’ operations, Intas is set to emerge as a top player in the UK gener...

If successful, this would be Aurobindo's largest ever acquisition, surpassing its $132.5 mn purchase of US vitamin maker Natrol Inc in 2014.

The remedy requires Teva to divest the drug portfolio to 11 firms and marks the largest drug divestiture order in an FTC pharmaceutical mer...

The deal, said to be valued up to $1.5 billion, has seen the Hyderabadbased Aurobindo Pharma emerge as one of the front runners in the init...

Orchid Chemicals & Pharmaceuticals to sell its injectables business to the US-based Hospira for around $400 million.

One of the biggest trans-continent deals in the generic pharma sector is likely open the floodgates of opportunities for the Indian pharma ...